RDGT

BEARISH

$2.23 Live

Ridgetech, Inc. · NASDAQ

$2.01 52W Range $760.5

RDGT Ridgetech, Inc. - Fundamental Analysis

BEARISH

Console Chart News

RDGT Stock | Fundamental Analysis & Investment Insights

NASDAQ • Healthcare • Pharmaceutical Retailers

Current Price Live

$2.23

52W High

$760.5

52W Low

$2.01

Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 18, 2026

Market cap

$2.0M

P/E

N/A

ROE

-8.0%

Profit margin

10.3%

Debt/Equity

0.16

Dividend yield

N/A

AI Analysis

AI-powered fundamental assessment

Confidence

95%

Despite a stable Piotroski F-Score of 6/9, RDGT is in a state of catastrophic financial and market collapse. The stock has plummeted from a 52-week high of $760.50 to $2.23, representing a near-total loss of value across all timeframes. Most critically, the provided earnings data is over a decade old (dating back to 2011), suggesting a complete failure in current financial reporting and transparency. The combination of negative revenue growth and a 0/100 technical trend indicates a terminal decline.

Key Strengths

Low Debt/Equity ratio (0.16)

Healthy Current Ratio (1.82) indicating short-term liquidity

Positive net profit margin (10.35%)

Stable Piotroski F-Score (6/9)

Low Price-to-Sales ratio (0.02)

Key Risks

Extreme price volatility and collapse (-98.5% 1Y change)

Severe lack of current financial reporting (last earnings data from 2011)

Negative year-over-year revenue growth (-11.70%)

Zero technical momentum (Technical Trend: 0/100)

Negative Return on Equity (-8.02%) and Return on Assets (-1.23%)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Weak

Value

Future

Past

Health

Dividend

AI Verdict

Terminal Decline

Key drivers: Catastrophic price collapse, Obsolete financial reporting, Negative revenue growth

Confidence

95%

Value

15/100

P/S of 0.02 is misleading given the lack of current earnings and market cap data.

Positives

Extremely low P/S ratio

Watchpoints

Lack of P/E and Graham Number due to missing data
Value trap characteristics

Future

5/100

Revenue Growth (YoY) is -11.70%.

Positives

No standout positives identified.

Watchpoints

Revenue growth is negative
No analyst targets or guidance

Past

0/100

Historical price performance is among the worst possible outcomes.

Positives

No standout positives identified.

Watchpoints

5Y change of -100%
1Y change of -98.5%

Health

50/100

Piotroski score suggests operational stability, but this is contradicted by the market price.

Positives

Piotroski F-Score of 6/9
Low leverage

Watchpoints

Missing Altman Z-Score
Negative ROE/ROA

Dividend

0/100

Payout ratio is 0.00%.

Positives

No standout positives identified.

Watchpoints

No dividend paid
0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$2.23

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for RDGT and closest competitors.

Updated 2026-04-17

Company	5Y	3Y	1Y	6M	1M	1W
RDGT Ridgetech, Inc. Primary	-100.0%	-99.9%	-98.5%	-99.1%	-99.3%	-11.5%
BDRX Biodexa Pharmaceuticals Plc Peer	-100.0%	-100.0%	-95.1%	-75.6%	-24.0%	-4.0%
IMCC IM Cannabis Corp. Peer	-99.9%	-91.4%	-72.7%	-81.3%	-57.0%	+6.5%
AKAN Akanda Corp. Peer	-100.0%	-100.0%	-96.4%	-95.4%	-13.6%	-6.7%
PRFX PRF Technologies Ltd. Peer	-99.7%	-98.6%	-73.4%	-56.0%	+17.2%	+3.0%

RDG

Ridgetech, Inc.

Primary

-100.0%

-99.9%

-98.5%

-99.1%

-99.3%

-11.5%

BDR

Biodexa Pharmaceuticals Plc

Peer

-100.0%

-95.1%

-75.6%

-24.0%

-4.0%

IMC

IM Cannabis Corp.

Peer

-99.9%

-91.4%

-72.7%

-81.3%

-57.0%

+6.5%

AKA

Akanda Corp.

Peer

-100.0%

-96.4%

-95.4%

-13.6%

-6.7%

PRF

PRF Technologies Ltd.

Peer

-99.7%

-98.6%

-73.4%

-56.0%

+17.2%

+3.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

N/A

0.0

0.02

-0.08

10.61

$2.0M

Profitability

Profit margins and return metrics

Profit Margin 10.35%

Operating Margin -0.12%

Gross Margin 3.24%

ROE -8.02%

ROA -1.23%

Growth

Revenue and earnings growth rates

Revenue Growth -11.7%

Earnings Growth N/A

Q/Q Revenue Growth N/A

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

0.16

Low debt

Current Ratio

1.82

Good

Quick Ratio

1.35

Good

Cash/Share

$357.01

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q3 2025

Total Assets

$0.1B

Liabilities

$0.0B

Equity

$0.0B

Debt/Equity

1.06x

Quarterly Earnings History

EPS performance vs analyst estimates

2011-02-15

$6119.97

-8.1% surprise

2010-11-15

$4319.98

-29.4% surprise

2010-08-16

$6119.97

+13.3% surprise

Healthcare Sector Comparison

Comparing RDGT against 421 companies in the Healthcare sector (25 bullish, 134 neutral, 262 bearish)

Return on Equity (ROE)

-8.02%

This Stock

-100.15%

Sector Avg

-92.0% (Below Avg)

Profit Margin

10.35%

This Stock

-13.63%

Sector Avg

-175.9% (Weaker)

Debt to Equity

0.16

This Stock

3.22

Sector Avg

-95.1% (Less Debt)

Revenue Growth

-11.7%

This Stock

121.05%

Sector Avg

-109.7% (Slower)

Current Ratio

1.82

This Stock

4.55

Sector Avg

-59.9% (Weaker)

Similar Companies

Peer comparison within the same industry

Company	AI Rating	Market Cap	P/E	ROE	Profit Margin	Price
RDGT Ridgetech, Inc.	BEARISH	$2.0M	-	-8.0%	10.3%	$2.23
BDRX Biodexa Pharmaceuticals Plc	BEARISH	$1.8M	-	-61.8%	-%	$2.15	Compare
IMCC IM Cannabis Corp.	BEARISH	$2.25M	-	-%	-20.7%	$0.36	Compare
AKAN Akanda Corp.	BEARISH	$1.73M	0.01	-60.9%	-266.3%	$0.82	Compare
PRFX PRF Technologies Ltd.	BEARISH	$2.31M	-	-90.4%	-%	$2.73	Compare

RDGT Ridgetech, Inc.

BEARISH

Mkt Cap

$2M

P/E

ROE

-8.0%

Price

$2.23

Compare with RDGT

IMCC IM Cannabis Corp.

Compare with RDGT

Compare with RDGT

PRFX PRF Technologies Ltd.

Compare with RDGT

SEC Filings

Recent regulatory filings from the SEC EDGAR database

20-F

ANNUAL REPORT

2025-07-28

RDGT filed its annual report on Form 20-F on July 28, 2025. Specific financial highlights and risk factors were not provided in the available metadata.

20-F

ANNUAL REPORT

2024-07-30

RDGT filed its Annual Report on Form 20-F on July 30, 2024. Due to the absence of provided excerpts, specific financial highlights and risk factors cannot be determined from the available metadata.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning RDGT from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V2 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends

RDGT

RDGT Ridgetech, Inc. - Fundamental Analysis

At a glance

AI Analysis

Key Strengths

Key Risks

Performance Snowflake

Stock Price & Analyst Targets

Multi-Horizon Performance vs Peers

Historical Performance Trends

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Valuation Metrics

Profitability

Growth

Financial Health

Financial Statement Flow

Quarterly Earnings History

Healthcare Sector Comparison

Similar Companies

SEC Filings

Past News Coverage

Wait — Don't Miss Out!